Robbins LLP Encourages Viatris Investors to Join Class Action Lawsuit Amidst Major Stock Drop

Robbins LLP Invites Viatris Shareholders to Take Action

On April 21, 2025, Robbins LLP announced the initiation of a class action lawsuit on behalf of investors who purchased or otherwise acquired securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024, and February 26, 2025. Viatris, a prominent global healthcare entity, has been embroiled in controversy following disclosures regarding its manufacturing facilities and subsequent financial performance.

The lawsuit emphasizes that investors may have been misled about critical aspects related to the inspection of Viatris’ facility in Indore, India. Allegations point to the company’s failure to communicate essential details surrounding the FDA’s warning letter and import alert that followed the inspection. Important information, including the timeline of the inspection and the nature of remediation efforts, was allegedly withheld from investors, which has raised significant concerns.

The Financial Fallout

Following the disappointing fiscal results reported on February 27, 2025, Viatris' stock price experienced a significant drop—from $11.24 on February 26 to $9.53 the following day, marking a decline of roughly 15.21%. The company attributed these dismal results to the financial ramifications of the FDA's warnings affecting the Indore facility. Investors who relied on Viatris' prior public statements are likely feeling the impact of these revelations, prompting Robbins LLP to reach out to potentially affected parties.

Taking Action

Shareholders with significant losses are encouraged to consider participating in the class action against Viatris. Those who wish to act as lead plaintiffs must submit their filings by June 3, 2025. The lead plaintiff serves as a representative for all class members, guiding the ongoing litigation. However, it's worth noting that participation in the case is not a requirement to qualify for any potential recovery. Absent class members can still benefit from the action without taking further steps.

Robbins LLP operates on a contingency fee basis—which means that shareholders incur no upfront costs or fees for legal representation. This model ensures that financial barriers do not prevent investors from seeking justice and accountability.

About Robbins LLP

Founded in 2002, Robbins LLP has built a notable reputation in shareholder rights litigation. The firm is dedicated to helping investors recover losses and enhancing corporate governance by holding company officials accountable for their actions. As part of their commitment, Robbins LLP provides resources for investors, including alerts regarding settlements and updates on corporate governance issues.

For further details or to determine your eligibility, you can fill out a form or reach out to attorney Aaron Dumas, Jr. via email or by calling (800) 350-6003.

In conclusion, if you have faced substantial losses due to your investment in Viatris, now is the time to take action. Stay informed and involved as Robbins LLP continues to advocate for your rights.